Chinese Severe Hemophilia a Children with High-Titer Inhibitors Obtain More Benefit from Intermediate-Dose Immune Tolerance Induction: The Interim Result of Lome Part a

被引：0
|
作者：
Li, Zhengping [1 ]
Wu, Runhui [1 ]
机构：
[1] Capital Med Univ, Beijing Childrens Hosp, Hematol Dept, Beijing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 17 条
  • [1] LOW-DOSE IMMUNE TOLERANCE INDUCTION THERAPY IN SEVERE HEMOPHILIA A CHILDREN WITH HIGH-TITER INHIBITOR
    Elalfy, M. S.
    Elghamry, I.
    Hassab, H.
    Elalfy, O.
    Andrawes, N. G.
    El-Ekiaby, M.
    HAEMOPHILIA, 2021, 27 : 97 - 97
  • [2] Low-Dose Immune Tolerance Induction for Hemophilia a Children with Poor-Risk High-Titer Inhibitors
    Li, Zekun
    Chen, Zhenping
    Cheng, Xiaoling
    Wu, Xinyi
    Gang, Li
    Zhen Yingzi
    Cai Siyu
    Poon, Man-Chiu
    Wu, Runhui
    BLOOD, 2019, 134
  • [3] Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes
    Sun, Jie
    Li, Zekun
    Li, Gang
    Huang, Kun
    Ai, Di
    Liu, Guoqing
    Yao, Wanru
    Xie, Xingjuan
    Gu, Hao
    Zhen, Yingzi
    Chen, Zhenping
    Wu, Runhui
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (07)
  • [4] Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China
    Li, Zekun
    Chen, Zhenping
    Cheng, Xiaoling
    Wu, Xinyi
    Li, Gang
    Zhen, Yingzi
    Cai, Siyu
    Poon, Man-Chiu
    Wu, Runhui
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (04) : 741 - 748
  • [5] Immune Tolerance Induction with High-Dose FVIII and Combined Immunosuppressive Therapy in a Patient with Severe Hemophilia A and High-Titer Inhibitor
    Ranta, S.
    Petrini, P.
    HAEMOPHILIA, 2016, 22 : 95 - 95
  • [6] What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?
    Janbain, Maissaa
    Pipe, Steven
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 648 - 649
  • [7] Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors
    Zanon, Ezio
    Pasca, Samantha
    Marino, Renato
    Molinari, Angelo Claudio
    BLOOD, 2018, 132
  • [8] Shorter Time Interval from Inhibitor Detection to Starting Low-Dose Immune Tolerance Induction Therapy Is Associated with Better Inhibitor Eradication Outcomes in Severe Hemophilia a Children with High-Titer Inhibitors in China
    Li, Zhengping
    Poon, Man-Chiu
    Liu, Guoqing
    Li, Zekun
    Sun, Jie
    Wu, Runhui
    BLOOD, 2022, 140 : 2757 - 2758
  • [9] Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: a pilot study in China (vol 3, pg 741, 2019)
    Li, Z.
    Chen, Z.
    Cheng, X.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (01) : 169 - 169
  • [10] Long-term outcomes of patients with severe hemophilia A and high titer inhibitors with partial tolerance after immune tolerance induction
    Batsuli, Glaivy
    Meeks, Shannon
    Sidonio, Robert
    HAEMOPHILIA, 2018, 24 : 48 - 49
12